Thirty years with HIV infection - Nonprogression is still puzzling: Lessons to be learned from controllers and long-term nonprogressors

AIDS Research and Treatment

Volumn 2012, Issue , 2012, Pages

  Gaardbo, Julie C ^a   Hartling, Hans J ^a   Gerstoft, Jan ^a   Nielsen, Susanne D ^a  

^a Rigshospitalet   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84873813167     PISSN: 20901240     EISSN: 20901259     Source Type: Journal    
DOI: 10.1155/2012/161584     Document Type: Review

References (166)

1. Mikhail M., Wang B., Saksena N. K., Mechanisms involved in non-progressive HIV disease. AIDS Reviews 2003 5 4 230 244 2-s2.0-1342329640 (Pubitemid 38258386)
2. Madec Y., Boufassa F., Porter K., Meyer L., Spontaneous control of viral load and CD4 cell count progression among HIV-1 seroconverters. AIDS 2005 19 17 2001 2007 2-s2.0-27944501720 (Pubitemid 41669025)
3. Dean M., Carrington M., Winkler C., Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study. Science 1996 273 5283 1856 1862
4. Eugen-Olsen J., Iversen A. K. N., Garred P., Koppelhus U., Pedersen C., Benfield T. L., Sorensen A. M., Katzenstein T., Dickmeiss E., Gerstoft J., Skinhøj P., Svejgaard A., Nielsen J. O., Hofmann B., Heterozygosity for a deletion in the CKR-5 gene leads to prolonged AIDS-free survival and slower CD4 T-cell decline in a cohort of HIV-seropositive individuals. AIDS 1997 11 3 305 310 2-s2.0-8044258978 10.1097/00002030-199703110-00007 (Pubitemid 27086969)
5. Klein M. R., Van Der Burg S. H., Hovenkamp E., Holwerda A. M., Drijfhout J. W., Melief C. J. M., Miedema F., Characterization of HLA-B57-restricted human immunodeficiency virus type 1 Gag- and RT-specific cytotoxic T lymphocyte responses. Journal of General Virology 1998 79 9 2191 2201 2-s2.0-0031709899 (Pubitemid 28423414)
6. Piacentini L., Biasin M., Fenizia C., Clerici M., Genetic correlates of protection against HIV infection: the ally within. Journal of Internal Medicine 2009 265 1 110 124 2-s2.0-57449088629 10.1111/j.1365-2796.2008.02041.x
7. Fellay J., Shianna K. V., Ge D., Colombo S., Ledergerber B., Weale M., Zhang K., Gumbs C., Castagna A., Cossarizza A., Cozzi-Lepri A., De Luca A., Easterbrook P., Francioli P., Mallal S., Martinez-Picado J., Miro J. M., Obel N., Smith J. P., Wyniger J., Descombes P., Antonarakis S. E., Letvin N. L., McMichael A. J., Haynes B. F., Telenti A., Goldstein D. B., A whole-genome association study of major determinants for host control of HIV-1. Science 2007 317 5840 944 947 2-s2.0-34548134145 10.1126/science.1143767 (Pubitemid 47301321)
8. + T-cells in HIV-Elite controllers. Current HIV Research 2010 8 6 471 481 2-s2.0-78249253936
9. Pereyra F., Jia X., McLaren P. J., Telenti A., De Bakker P. I. W., Walker B. D., The major genetic determinants of HIV-1 control affect HLA class I peptide presentation. Science 2010 330 6010 1551 1557 2-s2.0-78650084232 10.1126/science.1195271
10. Poropatich K., Sullivan D. J., Human immunodeficiency virus type 1 long-term non-progressors: the viral, genetic and immunological basis for disease non-progression. Journal of General Virology 2011 92 2 247 268 2-s2.0-79251472446 10.1099/vir.0.027102-0
11. Kirchhoff F., Greenough T. C., Brettler D. B., Sullivan J. L., Desrosiers R. C., Brief report: absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection. New England Journal of Medicine 1995 332 4 228 232 2-s2.0-0028835788 10.1056/NEJM199501263320405
12. Mariani R., Kirchhoff F., Greenough T. C., Sullivan J. L., Desrosiers R. C., Skowronski J., High frequency of defective nef alleles in a long-term survivor with nonprogressive human immunodeficiency virus type 1 infection. Journal of Virology 1996 70 11 7752 7764 2-s2.0-0029846223 (Pubitemid 26339081)
13. Iversen A. K. N., Shpaer E. G., Rodrigo A. G., Hirsch M. S., Walker B. D., Sheppard H. W., Merigan T. C., Mullins J. I., Persistence of attenuated rev genes in a human immunodeficiency virus type 1-infected asymptomatic individual. Journal of Virology 1995 69 9 5743 5753 2-s2.0-0029155437
14. Deacon N. J., Tsykin A., Solomon A., Smith K., Ludford-Menting M., Hooker D. J., McPhee D. A., Greenway A. L., Ellett A., Chatfield C., Lawson V. A., Crowe S., Maerz A., Sonza S., Learmont J., Sullivan J. S., Cunningham A., Dwyer D., Dowton D., Mills J., Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients. Science 1995 270 5238 988 991 2-s2.0-0028804160
15. Blankson J. N., Bailey J. R., Thayil S., Yang H. C., Lassen K., Lai J., Gandhi S. K., Siliciano J. D., Williams T. M., Siliciano R. F., Isolation and characterization of replication-competent human immunodeficiency virus type 1 from a subset of elite suppressors. Journal of Virology 2007 81 5 2508 2518 2-s2.0-33847176917 10.1128/JVI.02165-06
16. Bailey J. R., O'Connell K., Yang H. C., Han Y., Xu J., Jilek B., Williams T. M., Ray S. C., Siliciano R. F., Blankson J. N., Transmission of human immunodeficiency virus type 1 from a patient who developed AIDS to an elite suppressor. Journal of Virology 2008 82 15 7395 7410 2-s2.0-47749140088 10.1128/JVI.00800-08 (Pubitemid 352031208)
17. + T Cells in HIV Elite Controllers. Clinical Infectious Diseases 2010 51 2 233 238 2-s2.0-77954752400 10.1086/653677
18. + T cells from elite controllers resist HIV-1 infection by selective upregulation of p21. Journal of Clinical Investigation 2011 121 4 1549 1560 2-s2.0-79953305839 10.1172/JCI44539
19. + T cells from HIV-1-positive elite suppressors are fully susceptible to HIV-1 entry and productive infection. Journal of Virology 2011 85 2 979 986 2-s2.0-78650657805 10.1128/JVI.01721-10
20. Ruiz-Mateos E., MacHmach K., Romero-Sanchez M. C., Ferrando-Martinez S., Viciana P., Del Val M., Muñoz-Fernandez M. A., Genebat M., Leal M., Hepatitis C virus replication in caucasian HIV controllers. Journal of Viral Hepatitis 2011 18 7 e350 e357 2-s2.0-79959602420 10.1111/j.1365-2893.2010.01431. x
21. Sajadi M. M., Shakeri N., Talwani R., Redfield R. R., Hepatitis C infection in HIV-1 natural viral suppressors. AIDS 2010 24 11 1689 1695 2-s2.0-77954348400 10.1097/QAD.0b013e32833a2a32
22. Grabar S., Selinger-Leneman H., Abgrall S., Pialoux G., Weiss L., Costagliola D., Prevalence and comparative characteristics of long-term nonprogressors and HIV controller patients in the French Hospital Database on HIV. AIDS 2009 23 9 1163 1169 2-s2.0-67651087476 10.1097/QAD.0b013e32832b44c8
23. Petrucci A., Dorrucci M., Alliegro M. B., How many HIV-infected individuals may be defined as long-term nonprogressors? A report from the Italian Seroconversion Study. Italian Seroconversion Study Group (ISS). Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology 1997 14 3 243 248 (Pubitemid 27143261)
24. Lambotte O., Boufassa F., Madec Y., Nguyen A., Goujard C., Meyer L., Rouzioux C., Venet A., Oelfraissy J. F., HIV controllers: a homogeneous group of HIV-1-infected patients with spontaneous control of viral replication. Clinical Infectious Diseases 2005 41 7 1053 1056 2-s2.0-25444471257 10.1086/433188 (Pubitemid 41368233)
25. Okulicz J. F., Marconi V. C., Landrum M. L., Wegner S., Weintrob A., Ganesan A., Hale B., Crum-Cianflone N., Delmar J., Barthel V., Quinnan G., Agan B. K., Dolan M. J., Clinical outcomes of elite controllers, viremic controllers, and long-term nonprogressors in the US department of defense HIV natural history study. Journal of Infectious Diseases 2009 200 11 1714 1723 2-s2.0-72849130314 10.1086/646609
26. Boufassa F., Saez-Cirion A., Lechenadec J., Zucman D., Avettand-Fenoel V., Venet A., Rouzioux C., Delfraissy J. F., Lambotte O., Meyer L., CD4 dynamics over a 15 year-period among HIV controllers enrolled in the ANRS French Observatory. PLoS ONE 2011 6 4 2-s2.0-79955420643 10.1371/journal.pone.0018726 e18726
27. Hunt P. W., Natural control of HIV-1 replication and long-term nonprogression: overlapping but distinct phenotypes. Journal of Infectious Diseases 2009 200 11 1636 1638 2-s2.0-72849149790 10.1086/646610
28. Saag M., Deeks S. G., How do HIV elite controllers do what they do? Clinical Infectious Diseases 2010 51 2 239 241 2-s2.0-77954747572 10.1086/653678
29. Rodés B., Toro C., Paxinos E., Poveda E., Martinez-Padial M., Benito J. M., Jimenez V., Wrin T., Bassani S., Soriano V., Differences in disease progression in a cohort of long-term non-progressors after more than 16 years of HIV-1 infection. AIDS 2004 18 8 1109 1116 2-s2.0-2942532488 10.1097/00002030-200405210-00004 (Pubitemid 38738510)
30. Hütter G., Ganepola S., Eradication of HIV by transplantation of CCR5-deficient hematopoietic stem cells. The Scientific World Journal 2011 11 1068 1076 2-s2.0-79958125260 10.1100/tsw.2011.102
31. Moses A., Nelson J., Bagby G. C., The influence of human immunodeficiency virus-1 on hematopoiesis. Blood 1998 91 5 1479 1495 2-s2.0-0032030701 (Pubitemid 28110310)
32. Marandin A., Katz A., Oksenhendler E., Tulliez M., Picard F., Vainchenker W., Louache F., Loss of primitive hematopoietic progenitors in patients with human immunodeficiency virus infection. Blood 1996 88 12 4568 4578 2-s2.0-0029912733 (Pubitemid 26419139)
33. Nielsen S. D., Afzelius P., Dam-Larsen S., Nielsen C., Nielsen J. O., Mathiesen L., Hansen J. E. S., Effect of granulocyte colony-stimulating factor (G-CSF) in human immunodeficiency virus-infected patients: increase in numbers of naive CD4 cells and CD34 cells makes G-CSF a candidate for use in gene therapy or to support antiretroviral therapy. Journal of Infectious Diseases 1998 177 6 1733 1736 2-s2.0-0031750252 (Pubitemid 28243606)
34. Nielsen S. D., Clark D. R., Hutchings M., Dam-Larsen S., Repping S., Nielsen J. O., Mathiesen L., Miedema F., Hansen J. E. S., Treatment with granulocyte colony-stimulating factor decreases the capacity of hematopoietic progenitor cells for generation of lymphocytes in human immunodeficiency virus-infected persons. Journal of Infectious Diseases 1999 180 6 1819 1826 2-s2.0-0032710496 10.1086/315136
35. Alexaki A., Wigdahl B., HIV-1 infection of bone marrow hematopoietic progenitor cells and their role in trafficking and viral dissemination. PLoS Pathogens 2008 4 12 2-s2.0-58149261687 10.1371/journal.ppat.1000215 e1000215
36. Carter C. C., Onafuwa-Nuga A., McNamara L. A., Riddell J., Bixby D., Savona M. R., Collins K. L., HIV-1 infects multipotent progenitor cells causing cell death and establishing latent cellular reservoirs. Nature Medicine 2010 16 4 446 451 2-s2.0-77950531446 10.1038/nm.2109
37. Nielsen S. D., Jeppesen D. L., Kolte L., Clark D. R., Sørensen T. U., Dreves A. M., Ersbøll A. K., Ryder L. P., Valerius N. H., Nielsen J. O., Impaired progenitor cell function in HIV-negative infants of HIV-positive mothers results in decreased thymic output and low CD4 counts. Blood 2001 98 2 398 404 2-s2.0-0035880253 10.1182/blood.V98.2.398
38. Moir S., Ho J., Malaspina A., Wang W., DiPoto A. C., O'Shea M. A., Roby G., Kottilil S., Arthos J., Proschan M. A., Chun T. W., Fauci A. S., Evidence for HIV-associated B cell exhaustion in a dysfunctional memory B cell compartment in HIV-infected viremic individuals. Journal of Experimental Medicine 2008 205 8 1797 1805 2-s2.0-46049112339 10.1084/jem.20072683
39. Sauce D., Larsen M., Fastenackels S., Pauchard M., Ait-Mohand H., Schneider L., Guihot A., Boufassa F., Zaunders J., Iguertsira M., Bailey M., Gorochov G., Duvivier C., Carcelain G., Kelleher A. D., Simon A., Meyer L., Costagliola D., Deeks S. G., Lambotte O., Autran B., Hunt P. W., Katlama C., Appay V., HIV disease progression despite suppression of viral replication is associated with exhaustion of lymphopoiesis. Blood 2011 117 19 5142 5151 2-s2.0-79955962732 10.1182/blood-2011-01-331306
40. Douek D. C., Vescio R. A., Betts M. R., Brenchley J. M., Hill B. J., Zhang L., Berenson J. R., Collins R. H., Koup R. A., Assessment of thymic output in adults after haematopoietic stem-cell transplantation and prediction of T-cell reconstitution. The Lancet 2000 355 9218 1875 1881 2-s2.0-0034720664 (Pubitemid 30311880)
41. Haynes B. F., Markert M. L., Sempowski G. D., Patel D. D., Hale L. P., The role of the thymus in immune reconstitution in aging, bone marrow transplantation, and HIV-1 infection. Annual Review of Immunology 2000 18 529 560 2-s2.0-0034124915 10.1146/annurev.immunol.18.1.529 (Pubitemid 30365390)
42. Kolte L., Dreves A. M., Ersbøll A. K., Strandberg C., Jeppesen D. L., Nielsen J. O., Ryder L. P., Nielsen S. D., Association between larger thymic size and higher thymic output in human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy. Journal of Infectious Diseases 2002 185 11 1578 1585 2-s2.0-0036605699 10.1086/340418 (Pubitemid 34587519)
43. Hazenberg M. D., Otto S. A., Stuart J. W. T. C., Verschuren M. C. M., Borleffs J. C. C., Boucher C. A. B., Coutinho R. A., Lange J. M. A., De Wit T. F. R., Tsegaye A., Van Dongen J. J. M., Hamann D., De Boer R. J., Miedema F., Increased cell division but not thymic dysfunction rapidly affects the T-cell receptor excision circle content of the naive T cell population in HIV-1 infection. Nature Medicine 2000 6 9 1036 1042 2-s2.0-0033831175 10.1038/79549
44. Douek D. C., McFarland R. D., Keiser P. H., Gage E. A., Massey J. M., Haynes B. F., Polis M. A., Haase A. T., Feinberg M. B., Sullivan J. L., Jamieson B. D., Zack J. A., Picker L. J., Koup R. A., Changes in thymic function with age and during the treatment of HIV infection. Nature 1998 396 6712 690 695 2-s2.0-17444372347 10.1038/25374 (Pubitemid 29003949)
45. + T cell homeostasis and function in advanced HIV disease. Science 1997 277 5322 112 116 2-s2.0-0030868897 10.1126/science.277.5322.112 (Pubitemid 27450659)
46. + T-cell subsets in human immunodeficiency virus controllers: an ANRS EP36 study. Journal of Virology 2007 81 24 13904 13915 2-s2.0-37049027525 10.1128/JVI.01401-07 (Pubitemid 350247883)
47. Marchetti G., Riva A., Cesari M., Bellistrì G. M., Gianelli E., Casabianca A., Orlandi C., Magnani M., Meroni L., D'Arminio Monforte A., Mussini C., Cossarizza A., Galli M., Gori A., Paraninfo G., Carosi G., Sciandra M., Di Perri G., Quinzan G., Suter F., Concia E., Lattuada E., Rizzardini G., Capetti A., Beretta R., Fasolo M., Mazzotta F., Di Pietro M., Colombo C., Santoro D., HIV-infected long-term nonprogressors display a unique correlative pattern between the interleukin-7/interleukin-7 receptor circuit and T-cell homeostasis. HIV Medicine 2009 10 7 422 431 2-s2.0-67650682469 10.1111/j.1468-1293.2009. 00710.x
48. Westrop S. J., Qazi N. A., Pido-Lopez J., Nelson M. R., Gazzard B., Gotch F. M., Imami N., Transient nature of long-term nonprogression and broad virus-specific proliferative T-cell responses with sustained thymic output in HIV-1 controllers. PLoS ONE 2009 4 5 2-s2.0-65749112172 10.1371/journal.pone. 0005474 e5474
49. Fang R. H. T., Khatissian E., Monceaux V., Cumont M. C., Beq S., Ameisen J. C., Aubertin A. M., Israël N., Estaquier J., Hurtrel B., Disease progression in macaques with low SIV replication levels: on the relevance of TREC counts. AIDS 2005 19 7 663 673 2-s2.0-17844363294 (Pubitemid 40593071)
50. He H., Nehete P. N., Nehete B., Wieder E., Yang G., Buchl S., Sastry K. J., Functional impairment of central memory CD4 T cells is a potential early prognostic marker for changing viral load in SHIV-infected rhesus macaques. PLoS ONE 2011 6 5 2-s2.0-79955932359 10.1371/journal.pone.0019607 e19607
51. Goicoechea M., Smith D., May S., Mathews C., Spina C., Prevalence and T-cell phenotype of slow HIV disease progressors with robust HIV replication. Journal of Acquired Immune Deficiency Syndromes 2009 52 2 299 301 2-s2.0-70349665324 10.1097/QAI.0b013e3181b08d70
52. Resino S., Correa R., Bellon J. M., Munoz-Fernandez M. A., Preserved immune system in long-term asymptomatic vertically HIV-1 infected children. Clinical & Experimental Immunology 2003 132 1 105 112 (Pubitemid 36422601)
53. Khoury G., Rajasuriar R., Cameron P. U., Lewin S. R., The role of naive T-cells in HIV-1 pathogenesis: an emerging key playerc. Clinical Immunology 2011 141 3 253 267
54. Kimmig S., Przybylski G. K., Schmidt C. A., Laurisch K., Möwes B., Radbruch A., Thiel A., Two subsets of naive T helper cells with distinct T cell receptor excision circle content in human adult peripheral blood. Journal of Experimental Medicine 2002 195 6 789 794 2-s2.0-0037128660 10.1084/jem.20011756 (Pubitemid 34259723)
55. + T cells in normal individuals during aging and in lymphopenic children. European Journal of Immunology 2007 37 11 3270 3280 2-s2.0-36249011444 10.1002/eji.200636976 (Pubitemid 350131305)
56. Engsig F. N., Gerstoft J., Kronborg G., Larsen C. S., Pedersen G., Røge B., Jensen J., Nielsen L. N., Obel N., Long-term mortality in hiv patients virally suppressed for more than three years with incomplete CD4 recovery: a cohort study. BMC Infectious Diseases 2010 10, article 318 2-s2.0-77958572990 10.1186/1471-2334-10-318
57. Park L. S., Friend D. J., Schmierer A. E., Dower S. K., Namen A. E., Murine interleukin 7 (IL-7) receptor. Characterization on an IL-7-dependent cell line. Journal of Experimental Medicine 1990 171 4 1073 1089 2-s2.0-0025361098 (Pubitemid 20120134)
58. Llano A., Barretina J., Gutiérrez A., Blanco J., Cabrera C., Clotet B., Esté J. A., Interleukin-7 in plasma correlates with CD4 T-cell depletion and may be associated with emergence of syncytium-inducing variants in human immunodeficiency virus type 1-positive individuals. Journal of Virology 2001 75 21 10319 10325 2-s2.0-0034785564 10.1128/JVI.75.21.10319-10325.2001 (Pubitemid 32948062)
59. Rethi B., Fluur C., Atlas A., Krzyzowska M., Mowafi F., Grützmeier S., De Milito A., Bellocco R., Falk K. I., Rajnavölgyi É.., Chiodi F., Loss of IL-7R is associated with CD4 T-cell depletion, high interleukin-7 levels and CD28 down-regulation in HIV infected patients. AIDS 2005 19 18 2077 2086 2-s2.0-27944503411 (Pubitemid 41668995)
60. Fluur C., Rethi B., Thang P. H., Vivar N., Mowafi F., Lopalco L., Foppa C. U., Karlsson A., Tambussi G., Chiodi F., Relationship between serum IL-7 concentrations and lymphopenia upon different levels of HIV immune control. AIDS 2007 21 8 1048 1050 2-s2.0-34247602995 10.1097/QAD.0b013e32810c8caa (Pubitemid 46684339)
61. Giorgi J. V., Hultin L. E., McKeating J. A., Johnson T. D., Owens B., Jacobson L. P., Shih R., Lewis J., Wiley D. J., Phair J. P., Wolinsky S. M., Detels R., Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage. Journal of Infectious Diseases 1999 179 4 859 870 2-s2.0-0032955651 10.1086/314660 (Pubitemid 29159331)
62. Sousa A. E., Carneiro J., Meier-Schellersheim M., Grossman Z., Victorino R. M. M., CD4 T cell depletion is linked directly to immune activation in the pathogenesis of HIV-1 and HIV-2 but only indirectly to the viral load. Journal of Immunology 2002 169 6 3400 3406 2-s2.0-0037105617 (Pubitemid 35013190)
63. + T-cell depletion in HIV infection: are we closer to understanding the cause? Nature Medicine 2002 8 4 319 323 2-s2.0-0036103096 10.1038/nm0402-319 (Pubitemid 34407019)
64. Hazenberg M. D., Otto S. A., Van Benthem B. H. B., Roos M. T. L., Coutinho R. A., Lange J. M. A., Hamann D., Prins M., Miedema F., Persistent immune activation in HIV-1 infection is associated with progression to AIDS. AIDS 2003 17 13 1881 1888 2-s2.0-0041327667 10.1097/00002030-200309050-00006 (Pubitemid 37070273)
65. + T-lymphocyte activation in HIV-1 disease reflects an aspect of pathogenesis distinct from viral burden and immunodeficiency. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology 1998 18 4 332 340
66. + cell count, soluble immune activation markers, or combinations of HLA-DR and CD38 expression. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology 1997 16 2 83 92
67. + T cells is a marker of poor prognosis in HIV infection: results of 6 years of follow-up. Cytometry 1996 26 1 1 7 (Pubitemid 26110007)
68. + T cell levels: results of 6 years of follow-up. The Los Angeles Center, Multicenter AIDS Cohort Study. Journal of Acquired Immune Deficiency Syndromes 1993 6 8 904 912 (Pubitemid 23207458)
69. Pesanti E. L., Effects of bacterial pneumonitis on development of pneumocystosis in rats. American Review of Respiratory Disease 1982 125 6 723 726 2-s2.0-0019955315 (Pubitemid 12074589)
70. Owen R. E., Heitman J. W., Hirschkorn D. F., Lanteri M. C., Biswas H. H., Martin J. N., Krone M. R., Deeks S. G., Norris P. J., HIV+ elite controllers have low HIV-specific T-cell activation yet maintain strong, polyfunctional T-cell responses. AIDS 2010 24 8 1095 1105 2-s2.0-77951877224 10.1097/QAD.0b013e3283377a1e
71. Kamya P., Tsoukas C. M., Boulet S., Routy J. P., Thomas R., Cote P., Boulassel M. R., Lessard B., Kaul R., Ostrowski M., Kovacs C., Tremblay C. L., Bernard N. F., T cell Activation does not drive CD4 decline in longitudinally followed HIV-infected Elite Controllers. AIDS Research and Therapy 2011 8 1, article 20 2-s2.0-79959205943 10.1186/1742-6405-8-20
72. Bello G., Velasco-de-Castro C. A., Bongertz V., Santos Rodrigues C. A., Giacoia-Gripp C. B. W., Pilotto J. H., Grinsztejn B., Veloso V. G., Morgado M. G., Immune activation and antibody responses in non-progressing elite controller individuals infected with HIV-1. Journal of Medical Virology 2009 81 10 1681 1690 2-s2.0-69949153012 10.1002/jmv.21565
73. + T cell count in HIV-seropositive individuals with undetectable plasma HIV RNA levels in the absence of therapy. Journal of Infectious Diseases 2008 197 1 126 133 2-s2.0-39349088126 10.1086/524143 (Pubitemid 351263476)
74. Carbone J., Gil J., Benito J. M., Fernandez-Cruz E., Decreased expression of activation markers on CD4 T lymphocytes of HIV-infected long-term non-progressors. AIDS 2003 17 1 133 134 2-s2.0-0037415036 10.1097/00002030- 200301030-00021 (Pubitemid 36106311)
75. Broussard S. R., Staprans S. I., White R., Whitehead E. M., Feinberg M. B., Allan J. S., Simian immunodeficiency virus replicates to high levels in naturally infected African green monkeys without inducing immunologic or neurologic disease. Journal of Virology 2001 75 5 2262 2275 2-s2.0-0035121414 10.1128/JVI.75.5.2262-2275.2001 (Pubitemid 32147565)
76. Kaur A., Grant R. M., Means R. E., Mcclure H., Feinberg M., Johnson R. P., Diverse host responses and outcomes following simian immunodeficiency virus SIVmac239 infection in sooty mangabeys and rhesus macaques. Journal of Virology 1998 72 12 9597 9611 2-s2.0-0031775017 (Pubitemid 28520823)
77. Whittall T., Peters B., Rahman D., Kingsley C. I., Vaughan R., Lehner T., Immunogenic and tolerogenic signatures in human immunodeficiency virus (HIV)-infected controllers compared with progressors and a conversion strategy of virus control. Clinical & Experimental Immunology 2011 166 2 208 217
78. Vieillard V., Fausther-Bovendo H., Samri A., Debre P., Specific phenotypic and functional features of natural killer cells from HIV-infected long-term nonprogressors and HIV controllers. Journal of Acquired Immune Deficiency Syndromes 2010 53 5 564 573
79. Heil F., Hemmi H., Hochrein H., Ampenberger F., Kirschning C., Akira S., Lipford G., Wagner H., Bauer S., Species-specific recognition of single-stranded RNA via Till-like receptor 7 and 8. Science 2004 303 5663 1526 1529 2-s2.0-1542317578 10.1126/science.1093620 (Pubitemid 38314424)
80. Chang J. J., Altfeld M., TLR-mediated immune activation in HIV. Blood 2009 113 2 269 270 2-s2.0-61949158436 10.1182/blood-2008-10-184598
81. Meier A., Chang J. J., Chan E. S., Pollard R. B., Sidhu H. K., Kulkarni S., Wen T. F., Lindsay R. J., Orellana L., Mildvan D., Bazner S., Streeck H., Alter G., Lifson J. D., Carrington M., Bosch R. J., Robbins G. K., Altfeld M., Sex differences in the Toll-like receptor-mediated response of plasmacytoid dendritic cells to HIV-1. Nature Medicine 2009 15 8 955 959 2-s2.0-68349131723 10.1038/nm.2004
82. + T-cell apoptosis in HIV-1 viremic patients. Blood 2009 114 18 3854 3863 2-s2.0-70449713657 10.1182/blood-2009-04-217927
83. Oh D. Y., Baumann K., Hamouda O., Eckert J. K., Neumann K., Kücherer C., Bartmeyer B., Poggensee G., Oh N., Pruss A., Jessen H., Schumann R. R., A frequent functional toll-like receptor 7 polymorphism is associated with accelerated HIV-1 disease progression. AIDS 2009 23 3 297 307 2-s2.0-59849086382 10.1097/QAD.0b013e32831fb540
84. Chang J., Lindsay R. J., Kulkarni S., Lifson J. D., Carrington M., Altfeld M., Polymorphisms in interferon regulatory factor 7 reduce interferon- responses of plasmacytoid dendritic cells to HIV-1. AIDS 2011 25 5 715 717 2-s2.0-79952454424 10.1097/QAD.0b013e328343c186
85. Machmach K., Leal M., Gras C., Viciana P., Genebat M., Franco E., Boufassa F., Lambotte O., Herbeuval J. P., Ruiz-Mateos E., Plasmacytoid dendritic cells reduce HIV production in elite controllers. Journal of Virology 2012 86 8 4245 4252
86. Mandl J. N., Barry A. P., Vanderford T. H., Kozyr N., Chavan R., Klucking S., Barrat F. J., Coffman R. L., Staprans S. I., Feinberg M. B., Divergent TLR7 and TLR9 signaling and type I interferon production distinguish pathogenic and nonpathogenic AIDS virus infections. Nature Medicine 2008 14 10 1077 1087 2-s2.0-53549103852 10.1038/nm.1871
87. Meyaard L., Otto S. A., Jonker R. R., Mijnster M. J., Keet R. P. M., Miedema F., Programmed death of T cells in HIV-1 infection. Science 1992 257 5067 217 219 2-s2.0-0026667222
88. + T cells and their association with HIV-1-induced T cell dysfunction. Journal of Immunology 2005 175 12 8415 8423 2-s2.0-29144470075 (Pubitemid 41798409)
89. Franceschi C., Franceschini M. G., Boschini A., Trenti T., Nuzzo C., Castellani G., Smacchia C., De Rienzo B., Roncaglia R., Portolani M., Pietrosemoli P., Meacci M., Pecorari M., Sabbatini A., Malorni W., Cossarizza A., Phenotypic characteristics and tendency to apoptosis of peripheral blood mononuclear cells from HIV+ long term non progressors. Cell Death and Differentiation 1997 4 8 815 823 2-s2.0-0000892945 (Pubitemid 127680718)
90. Schweneker M., Favre D., Martin J. N., Deeks S. G., McCune J. M., HIV-induced changes in T cell signaling pathways. Journal of Immunology 2008 180 10 6490 6500 2-s2.0-45549103855
91. + lymphocyte phenotype and cytokine production in long-term non-progressor and in progressor patients with HIV-1 infection. Clinical and Experimental Immunology 1996 105 2 220 224 2-s2.0-0030017679 (Pubitemid 26246937)
92. + T cells go out of stock. Nature Immunology 2000 1 4 285 289 2-s2.0-0034304597
93. + T cells: a population of T cells with immune regulatory activities in vitro. European Journal of Immunology 1998 28 11 3435 3447 (Pubitemid 28510754)
94. +CD2 5 high regulatory cells in human peripheral blood. Journal of Immunology 2001 167 3 1245 1253 2-s2.0-0035413350 (Pubitemid 32703119)
95. + regulatory T cells in operational tolerance after living donor liver transplantation. Transplantation Proceedings 2005 37 1 37 39 2-s2.0-16244404959 10.1016/j.transproceed.2004.12. 259 (Pubitemid 40459681)
96. + regulatory T cells in immunological tolerance to self and non-self. Nature Immunology 2005 6 4 345 352 2-s2.0-16844365788 10.1038/ni1178 (Pubitemid 41716771)
97. Bernardes S. S., Borges I. K., Lima J. E., de Azevedo P., Conchon-Costa I., Felipe I., Saridakis H. O., Watanabe M. A. E., Involvement of regulatory T cells in HIV immunopathogenesis. Current HIV Research 2010 8 4 340 346 2-s2.0-77953527624 10.2174/157016210791208613
98. Gaardbo J. C., Nielsen S. D., Vedel S. J., Ersbøll A. K., Harritshøj L., Ryder L. P., Nielsen J. O., Kolte L., Regulatory T cells in human immunodeficiency virus-infected patients are elevated and independent of immunological and virological status, as well as initiation of highly active anti-retroviral therapy. Clinical and Experimental Immunology 2008 154 1 80 86 2-s2.0-51349160211 10.1111/j.1365-2249.2008.03725.x
99. + regulatory T cells, which suppress HIV-specific CD4 T-cell responses in HIV-infected patients. Blood 2004 104 10 3249 3256 2-s2.0-8644280556 10.1182/blood-2004-01-0365 (Pubitemid 39507143)
100. Lim A., Tan D., Price P., Kamarulzaman A., Tan H. Y., James I., French M. A., Proportions of circulating T cells with a regulatory cell phenotype increase with HIV-associated immune activation and remain high on antiretroviral therapy. AIDS 2007 21 12 1525 1534 2-s2.0-34447578626 10.1097/QAD. 0b013e32825eab8b (Pubitemid 47075472)
101. Kanwar B., Favre D., McCune J. M., Th17 and regulatory T cells: implications for AIDS pathogenesis. Current Opinion in HIV and AIDS 2010 5 2 151 157 2-s2.0-76949108202 10.1097/COH.0b013e328335c0c1
102. Brandt L., Benfield T., Mens H., Low level of regulatory T cells and maintenance of balance between regulatory T cells and TH17 cells in HIV-1-infected elite controllers. Journal of Acquired Immune Deficiency Syndromes 2011 57 2 101 108
103. + T cells in HIV-1-infected typical progressors, but not in long-term non-progressors. Immunology 2009 128 supplement 1 e366 e375 2-s2.0-68249136806 10.1111/j.1365-2567.2008.02978.x
104. + regulatory T cells in HIV-exposed seronegative persons and HIV-infected persons with different disease progressions. Viral Immunology 2011 24 1 57 60 2-s2.0-79951797419 10.1089/vim.2010.0079
105. + regulatory T cells in the peripheral blood of
106. Hunt P. W., Landay A. L., Sinclair E., Martinson J. A., Hatano H., Emu B., Norris P. J., Busch M. P., Martin J. N., Brooks C., McCune J. M., Deeks S. G., A low T regulatory cell response may contribute to both viral control and generalized immune activation in HIV controllers. PLoS ONE 2011 6 1 2-s2.0-79551649723 10.1371/journal.pone.0015924 e15924
107. + regulatory T cells: a systematic review. Biomedical and Environmental Sciences 2010 23 4 327 332
108. Bettelli E., Carrier Y., Gao W., Korn T., Strom T. B., Oukka M., Weiner H. L., Kuchroo V. K., Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006 441 7090 235 238 2-s2.0-33646577466 10.1038/nature04753
109. Favre D., Lederer S., Kanwar B., Ma Z. M., Proll S., Kasakow Z., Mold J., Swainson L., Barbour J. D., Baskin C. R., Palermo R., Pandrea I., Miller C. J., Katze M. G., McCune J. M., Critical loss of the balance between Th17 and T regulatory cell populations in pathogenic SIV infection. PLoS Pathogens 2009 5 2 2-s2.0-61449115882 10.1371/journal.ppat.1000295 e1000295
110. Favre D., Mold J., Hunt P. W., Kanwar B., Loke P., Seu L., Barbour J. D., Lowe M. M., Jayawardene A., Aweeka F., Huang Y., Douek D. C., Brenchley J. M., Martin J. N., Hecht F. M., Deeks S. G., McCune J. M., Tryptophan catabolism by indoleamine 2, 3-dioxygenase 1 alters the balance of TH17 to regulatory T cells in HIV disease. Science Translational Medicine 2010 2 32, article 32ra36 2-s2.0-77952977625 10.1126/scitranslmed.3000632
111. Hunt P. W., Th17, gut, and HIV: therapeutic implications. Current Opinion in HIV and AIDS 2010 5 2 189 193
112. Hartigan-O'Connor D. J., Hirao L. A., McCune J. M., Dandekar S., Th17 cells and regulatory T cells in elite control over HIV and SIV. Current Opinion in HIV and AIDS 2011 6 3 221 227 2-s2.0-79955479493 10.1097/COH.0b013e32834577b3
113. Salgado M., Rallon N. I., Rodes B., Lopez M., Soriano V., Benito J. M., Long-term non-progressors display a greater number of Th17 cells than HIV-infected typical progressors. Clinical Immunology 2011 139 2 110 114
114. Wang L., Robb C. W., Cloyd M. W., HIV induces homing of resting T lymphocytes to lymph nodes. Virology 1997 228 2 141 152 2-s2.0-0031575537 10.1006/viro.1996.8397 (Pubitemid 27238780)
115. Wang L., Chen J. J. Y., Gelman B. B., Konig R., Cloyd M. W., A novel mechanism of CD4 lymphocyte depletion involves effects of HIV on resting lymphocytes: induction of lymph node homing and apoptosis upon secondary signaling through homing receptors. Journal of Immunology 1999 162 1 268 276 2-s2.0-0032909114 (Pubitemid 29018929)
116. Cloyd M. W., Chen J. J. Y., Adeqboyega P., Wang L., How does HIV cause depletion of CD4 lymphocytes? A mechanism involving virus signaling through its cellular receptors. Current Molecular Medicine 2001 1 5 545 550 2-s2.0-0035524291 (Pubitemid 33772034)
117. + regulatory T cells are highly increased in untreated HIV infection and normalize after suppressive HAART. Blood 2006 108 9 3072 3078 2-s2.0-33750320502 10.1182/blood-2006-04- 016923
118. Shaw J. M., Hunt P. W., Critchfield J. W., Increased frequency of regulatory T cells accompanies increased immune activation in rectal mucosae of HIV-positive noncontrollers. Journal of Virology 2011 85 21 1122 1134
119. + T cells in multiple tissues during acute SIV infection. Nature 2005 434 7037 1093 1097 2-s2.0-17844374605 10.1038/nature03501 (Pubitemid 40663481)
120. + T-cell depletion in gut lymphoid tissue during primary human immunodeficiency virus type 1 infection and substantial delay in restoration following highly active antiretroviral therapy. Journal of Virology 2003 77 21 11708 11717 2-s2.0-0142092389 10.1128/JVI.77.21.11708-11717. 2003 (Pubitemid 37271669)
121. Schacker T. W., Nguyen P. L., Beilman G. J., Wolinsky S., Larson M., Reilly C., Haase A. T., Collagen deposition in HIV-1 infected lymphatic tissues and T cell homeostasis. Journal of Clinical Investigation 2002 110 8 1133 1139 2-s2.0-0036801658 10.1172/JCI200216413 (Pubitemid 35215894)
122. Finkel T. H., Tudor-Williams G., Banda N. K., Cotton M. F., Curiel T., Monks C., Baba T. W., Ruprecht R. M., Kupfer A., Apoptosis occurs predominantly in bystander cells and not in productively infected cells of HIV- and SIV-infected lymph nodes. Nature Medicine 1995 1 2 129 134 2-s2.0-0028912254
123. Pantaleo G., Menzo S., Vaccarezza M., Graziosi C., Cohen O. J., Demarest J. F., Montefiori D., Orenstein J. M., Fox C., Schrager L. K., Margolick J. B., Buchbinder S., Giorgi J. V., Fauci A. S., Studies in subjects with long-term nonprogressive human immunodeficiency virus infection. New England Journal of Medicine 1995 332 4 209 216 2-s2.0-0028861377 10.1056/NEJM199501263320402
124. Brenchley J. M., Douek D. C., The mucosal barrier and immune activation in HIV pathogenesis. Current Opinion in HIV and AIDS 2008 3 3 356 361 2-s2.0-42049095290 10.1097/COH.0b013e3282f9ae9c (Pubitemid 351521021)
125. + T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract. Journal of Experimental Medicine 2004 200 6 749 759 2-s2.0-4644342929 10.1084/jem.20040874 (Pubitemid 39299461)
126. + T lymphocytes from effector sites in the gastrointestinal tract. Journal of Experimental Medicine 2004 200 6 761 770 2-s2.0-4644289983 10.1084/jem.20041196 (Pubitemid 39299462)
127. Merlini E., Bai F., Bellistrì G. M., Tincati C., d'Arminio Monforte A., Marchetti G., Evidence for polymicrobic flora translocating in peripheral blood of HIV-infected patients with poor immune response to antiretroviral therapy. PLoS ONE 2011 6 4 2-s2.0-79954536349 10.1371/journal.pone.0018580 e18580
128. Brenchley J. M., Price D. A., Schacker T. W., Asher T. E., Silvestri G., Rao S., Kazzaz Z., Bornstein E., Lambotte O., Altmann D., Blazar B. R., Rodriguez B., Teixeira-Johnson L., Landay A., Martin J. N., Hecht F. M., Picker L. J., Lederman M. M., Deeks S. G., Douek D. C., Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nature Medicine 2006 12 12 1365 1371 2-s2.0-33845532053 10.1038/nm1511 (Pubitemid 44924494)
129. Ling B., Veazey R. S., Hart M., Lackner A. A., Kuroda M., Pahar B., Marx P. A., Early restoration of mucosal CD4 memory CCR5 T cells in the gut of SIV-infected rhesus predicts long term non-progression. AIDS 2007 21 18 2377 2385 2-s2.0-36349010757 10.1097/QAD.0b013e3282f08b32 (Pubitemid 350145169)
130. Ferre A. L., Hunt P. W., Critchfield J. W., Young D. H., Morris M. M., Garcia J. C., Pollard R. B., Yee H. F., Martin J. N., Deeks S. G., Shacklett B. L., Mucosal immune responses to HIV-1 in elite controllers: a potential correlate of immune control. Blood 2009 113 17 3978 3989 2-s2.0-65449126294 10.1182/blood-2008-10-182709
131. + T-cell responses. Journal of Virology 2010 84 21 11020 11029 2-s2.0-77957944425 10.1128/JVI.00980-10
132. Migueles S. A., Tilton J. C., Connors M., Advances in understanding immunologic control of HIV infection. Current HIV/AIDS Reports 2004 1 1 12 17 2-s2.0-24144455711
133. Porichis F., Kaufmann D. E., HIV-specific CD4 T cells and immune control of viral replication. Current Opinion in HIV and AIDS 2011 6 3 174 180 2-s2.0-79955476141 10.1097/COH.0b013e3283454058
134. + cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. Journal of Virology 1994 68 9 6103 6110 2-s2.0-0028041344 (Pubitemid 24258634)
135. Koup R. A., Safrit J. T., Cao Y., Andrews C. A., McLeod G., Borkowsky W., Farthing C., Ho D. D., Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. Journal of Virology 1994 68 7 4650 4655 2-s2.0-0028337166 (Pubitemid 24183063)
136. Letvin N. L., Schmitz J. E., Jordan H. L., Seth A., Hirsch V. M., Reimann K. A., Kuroda M. J., Cytotoxic T lymphocytes specific for the simian immunodeficiency virus. Immunological Reviews 1999 170 127 134 2-s2.0-0032860663 10.1111/j.1600-065X.1999.tb01334.x (Pubitemid 29490750)
137. Pontesilli O., Klein M. R., Kerkhof-Garde S. R., Pakker N. G., De Wolf F., Schuitemaker H., Miedema F., Longitudinal analysis of human immunodeficiency virus type 1-specific cytotoxic T lymphocyte responses: a predominant gag-specific response is associated with nonprogressive infection. Journal of Infectious Diseases 1998 178 4 1008 1018 2-s2.0-0031664158 (Pubitemid 28452192)
138. + T cells. Blood 2006 107 12 4781 4789 2-s2.0-33646686040 10.1182/blood-2005-12-4818 (Pubitemid 43882629)
139. + T cells specific for human immunodeficiency virus, hepatitis C virus, and cytomegalovirus reveal differences in frequency, immunodominance, phenotype, and interleukin-2 responsiveness. Journal of Virology 2009 83 6 2728 2742 2-s2.0-62749134469 10.1128/JVI.02128-08
140. + T cells in patients with different progression of HIV infection over 4 years. Journal of Acquired Immune Deficiency Syndromes 2010 55 1 29 38
141. + T cells correlates with disease progression and defines a reversible immune dysfunction. Nature Immunology 2007 8 11 1246 1254 2-s2.0-34548680261 10.1038/ni1515 (Pubitemid 350011764)
142. + T cells is required for HIV-infected cell elimination associated with immune control. Immunity 2008 29 6 1009 1021 2-s2.0-57449109484 10.1016/j.immuni.2008.10.010
143. Verkoczy L., Kelsoe G., Moody M. A., Haynes B. F., Role of immune mechanisms in induction of HIV-1 broadly neutralizing antibodies. Current Opinion in Immunology 2011 23 3 383 390 2-s2.0-79957726572 10.1016/j.coi.2011. 04.003
144. Doria-Rose N. A., Klein R. M., Daniels M. G., O'Dell S., Nason M., Lapedes A., Bhattacharya T., Migueles S. A., Wyatt R. T., Korber B. T., Mascola J. R., Connors M., Breadth of human immunodeficiency virus-specific neutralizing activity in sera: clustering analysis and association with clinical variables. Journal of Virology 2010 84 3 1631 1636 2-s2.0-73949084963 10.1128/JVI.01482-09
145. Sajadi M. M., Guan Y., DeVico A. L., Correlation between circulating HIV-1 RNA and broad HIV-1 neutralizing antibody activity. Journal of Acquired Immune Deficiency Syndromes 2011 57 1 9 15
146. Lambotte O., Ferrari G., Moog C., Yates N. L., Liao H. X., Parks R. J., Hicks C. B., Owzar K., Tomaras G. D., Montefiori D. C., Haynes B. F., Jean-François Delfraissy, Heterogeneous neutralizing antibody and antibody-dependent cell cytotoxicity responses in HIV-1 elite controllers. AIDS 2009 23 8 897 906 2-s2.0-67149120819 10.1097/QAD.0b013e328329f97d
147. Mahalanabis M., Jayaraman P., Miura T., Pereyra F., Chester E. M., Richardson B., Walker B., Haigwood N. L., Continuous viral escape and selection by autologous neutralizing antibodies in drug-naïve human immunodeficiency virus controllers. Journal of Virology 2009 83 2 662 672 2-s2.0-58149487646 10.1128/JVI.01328-08
148. Yamamoto H., Kawada M., Tsukamoto T., Takeda A., Igarashi H., Miyazawa M., Naruse T., Yasunami M., Kimura A., Matano T., Vaccine-based, long-term, stable control of simian/human immunodeficiency virus 89.6PD replication in rhesus macaques. Journal of General Virology 2007 88 2 652 659 2-s2.0-33846840778 10.1099/vir.0.82469-0 (Pubitemid 46210905)
149. Choudhary S. K., Vrisekoop N., Jansen C. A., Otto S. A., Schuitemaker H., Miedema F., Camerini D., Low immune activation despite high levels of pathogenic human immunodeficiency virus type 1 results in long-term asymptomatic disease. Journal of Virology 2007 81 16 8838 8842 2-s2.0-34547752932 10.1128/JVI.02663-06 (Pubitemid 47242858)
150. + T cells may contribute to viral persistence in HIV controllers. Clinical Infectious Diseases 2011 52 5 681 687 2-s2.0-79951837963 10.1093/cid/ciq202
151. Chomont N., El-Far M., Ancuta P., Trautmann L., Procopio F. A., Yassine-Diab B., Boucher G., Boulassel M. R., Ghattas G., Brenchley J. M., Schacker T. W., Hill B. J., Douek D. C., Routy J. P., Haddad E. K., Sékaly R. P., HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation. Nature Medicine 2009 15 8 893 900 2-s2.0-68349139711 10.1038/nm.1972
152. Chun T. W., Carruth L., Finzi D., Shen X., DiGiuseppe J. A., Taylor H., Hermankova M., Chadwick K., Margolick J., Quinn T. C., Kuo Y. H., Brookmeyer R., Zeiger M. A., Barditch-Crovo P., Siliciano R. F., Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection. Nature 1997 387 6629 183 188 2-s2.0-0030913366 10.1038/387183a0 (Pubitemid 27209433)
153. Chun T. W., Nickle D. C., Justement J. S., Meyers J. H., Roby G., Hallahan C. W., Kottilil S., Moir S., Mican J. M., Mullins J. I., Ward D. J., Kovacs J. A., Mannon P. J., Fauci A. S., Persistence of HIV in gut-associated lymphoid tissue despite long-term antiretroviral therapy. Journal of Infectious Diseases 2008 197 5 714 720 2-s2.0-40549092339 10.1086/527324 (Pubitemid 351364472)
154. Brenchley J. M., Price D. A., Schacker T. W., Asher T. E., Silvestri G., Rao S., Kazzaz Z., Bornstein E., Lambotte O., Altmann D., Blazar B. R., Rodriguez B., Teixeira-Johnson L., Landay A., Martin J. N., Hecht F. M., Picker L. J., Lederman M. M., Deeks S. G., Douek D. C., Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nature Medicine 2006 12 12 1365 1371 2-s2.0-33845532053 10.1038/nm1511 (Pubitemid 44924494)
155. Graf E. H., Mexas A. M., Yu J. J., Shaheen F., Liszewski M. K., Di Mascio M., Migueles S. A., Connors M., O'Doherty U., Elite suppressors harbor low levels of integrated HIV DNA and high levels of 2-LTR circular HIV DNA compared to HIV+ patients on and off HAART. PLoS Pathogens 2011 7 2 2-s2.0-79952072932 10.1371/journal.ppat.1001300 e1001300
156. + T cells from HIV controllers. Blood 2011 118 4 955 964 2-s2.0-79961008229 10.1182/blood-2010-12-327106
157. Miura T., Brumme Z. L., Brockman M. A., Rosato P., Sela J., Brumme C. J., Pereyra F., Kaufmann D. E., Trocha A., Block B. L., Daar E. S., Connick E., Jessen H., Kelleher A. D., Rosenberg E., Markowitz M., Schafer K., Vaida F., Iwamoto A., Little S., Walker B. D., Impaired replication capacity of acute/early viruses in persons who become HIV controllers. Journal of Virology 2010 84 15 7581 7591 2-s2.0-77954512323 10.1128/JVI.00286-10
158. Avettand-Fenoel V., Prazuck T., Hocqueloux L., Melard A., Michau C., Kerdraon R., Agoute E., Rouzioux C., HIV-DNA in rectal cells is well correlated with HIV-DNA in blood in different groups of patients, including long-term non-progressors. AIDS 2008 22 14 1880 1882 2-s2.0-66349103438 10.1097/QAD.0b013e32830fbdbc
159. Ling B., Mohan M., Lackner A. A., Green L. C., Marx P. A., Doyle L. A., Veazey R. S., The large intestine as a major reservoir for simian immunodeficiency virus in macaques with long-term, nonprogressing infection. Journal of Infectious Diseases 2010 202 12 1846 1854 2-s2.0-78650358966 10.1086/657413
160. Lefrère J. J., Morand-Joubert L., Mariotti M., Bludau H., Burghoffer B., Petit J. C., Roudot-Thoraval F., Even individuals considered as long-term nonprogressors show biological signs of progression after 10 years of human immunodeficiency virus infection. Blood 1997 90 3 1133 1140 2-s2.0-1842414800 (Pubitemid 27314149)
161. Hatano H., Delwart E. L., Norris P. J., Lee T. H., Dunn-Williams J., Hunt P. W., Hoh R., Stramer S. L., Linnen J. M., McCune J. M., Martin J. N., Busch M. P., Deeks S. G., Evidence for persistent low-level viremia in individuals who control human immunodeficiency virus in the absence of antiretroviral therapy. Journal of Virology 2009 83 1 329 335 2-s2.0-58149382617 10.1128/JVI.01763-08
162. Pereyra F., Palmer S., Miura T., Block B. L., Wiegand A., Rothchild A. C., Baker B., Rosenberg R., Cutrell E., Seaman M. S., Coffin J. M., Walker B. D., Persistent low-level viremia in HIV-1 elite controllers and relationship to immunologic parameters. Journal of Infectious Diseases 2009 200 6 984 990 2-s2.0-70349434887 10.1086/605446
163. Pereyra F., Addo M. M., Kaufmann D. E., Liu Y., Miura T., Rathod A., Baker B., Trocha A., Rosenberg R., Mackey E., Ueda P., Lu Z., Cohen D., Wrin T., Petropoulos C. J., Rosenberg E. S., Walker B. D., Genetic and immunologic heterogeneity among persons who control HIV infection in the absence of therapy. Journal of Infectious Diseases 2008 197 4 563 571 2-s2.0-40049094957 10.1086/526786 (Pubitemid 351321534)
164. López M., Soriano V., Peris-Pertusa A., Rallón N., Restrepo C., Benito J. M., Elite controllers display higher activation on central memory CD8 T cells than HIV patients successfully on HAART. AIDS Research and Human Retroviruses 2011 27 2 157 165 2-s2.0-79951707505 10.1089/aid.2010.0107
165. Okulicz J. F., Grandits G. A., Weintrob A. C., Landrum M. L., Ganesan A., Crum-Cianflone N. F., Agan B. K., Marconi V. C., CD4 T cell count reconstitution in HIV controllers after highly active antiretroviral therapy. Clinical Infectious Diseases 2010 50 8 1187 1191 2-s2.0-77950278694 10.1086/651421
166. Sedaghat A. R., Rastegar D. A., OConnell K. A., Dinoso J. B., Wilke C. O., Blankson J. N., T cell dynamics and the response to HAART in a cohort of HIV-1-infected elite suppressors. Clinical Infectious Diseases 2009 49 11 1763 1766 2-s2.0-72849143512 10.1086/648081